erythromycin has been researched along with aminosalicylic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baraia-Etxaburu, J; Ibarrola, M; Miguel Santamaría, J; Sánchez, R; Teira, R; Unzaga, J | 1 |
| FEINGOLD, DS | 1 |
| DOROZHKOVA, IR; DYKHNO, MM; KOCHEMASOVA, ZN | 1 |
| EQUIOIZ, LP; LAPERUTA, AM; SILVA, GA | 1 |
| ASHTON, B; SEVAG, MG | 1 |
2 review(s) available for erythromycin and aminosalicylic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
ANTIMICROBIAL CHEMOTHERAPEUTIC AGENTS: THE NATURE OF THEIR ACTION AND SELECTIVE TOXICITY (CONCLUDED).
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Chloramphenicol; DNA; DNA, Bacterial; Erythromycin; Griseofulvin; Isoniazid; Oleandomycin; RNA; RNA, Bacterial; Spiramycin; Sulfonamides; Tetracycline | 1963 |
11 other study(ies) available for erythromycin and aminosalicylic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Aminosalicylic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Ethambutol; Fatal Outcome; Female; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Streptomycin; Treatment Refusal | 2001 |
[STUDIES ON MYCOBACTERIAL SENSITIVITY TO ANTIBIOTICS AND CHEMOTHERAPEUTIC AGENTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chlortetracycline; Colistin; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Research; Streptomycin; Tetracycline; Tetrazolium Salts | 1963 |
[CLINICAL EXPERIENCE WITH D.A.T.C].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Isoniazid; Pharmacology; Phenylthiourea; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
EVOLUTION AND PREVENTION OF DRUG-RESISTANCE.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Chloramphenicol; DNA; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Genetics; Novobiocin; Penicillins; Pharmacology; Protein Synthesis Inhibitors; Quinacrine; Research; Spermine; Staphylococcus; Streptomycin; Sulfathiazoles; Tetracycline | 1964 |